High asymptomatic carriage with the Omicron variant in South Africa

dc.contributor.authorGarrett, N.
dc.contributor.authorTapley, Asa
dc.contributor.authorAndriesen, Jessica
dc.contributor.authorSeocharan, Ishen
dc.contributor.authorFisher, Leigh H.
dc.contributor.authorBunts, Lisa
dc.contributor.authorEpsy, Nicole
dc.contributor.authorWallis, Carole L.
dc.contributor.authorRandhawa, April Kaur
dc.contributor.authorMiner, Maurine D.
dc.contributor.authorKetter, Nzeera
dc.contributor.authorYacovone, Margaret
dc.contributor.authorGoga, Ameena Ebrahim
dc.contributor.authorHuang, Yunda
dc.contributor.authorHural, John
dc.contributor.authorKotze, Philip
dc.contributor.authorBekker, Linda‑Gail
dc.contributor.authorGray, Glenda E.
dc.contributor.authorCorey, Lawrence
dc.contributor.authorUbuntu Study Team
dc.date.accessioned2023-05-12T12:15:51Z
dc.date.available2023-05-12T12:15:51Z
dc.date.issued2022-07
dc.description.abstractWe report a 23% asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) Omicron carriage rate in participants being enrolled into a clinical trial in South Africa, 15-fold higher than in trials before Omicron. We also found lower CD4 + T-cell counts in persons with human immunodeficiency virus (HIV) strongly correlated with increased odds of being SARS-CoV-2 polymerase chain reaction (PCR) positive.en_US
dc.description.departmentPaediatrics and Child Healthen_US
dc.description.librarianam2023en_US
dc.description.sponsorshipThe National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) grants. The Sisonke study was funded by the National Treasury of South Africa; the National Department of Health; Solidarity Response Fund NPC; The Michael & Susan Dell Foundation; The Elma Vaccines and Immunization Foundation; and the Bill & Melinda Gates Foundation.en_US
dc.description.urihttps://academic.oup.com/ciden_US
dc.identifier.citationGarreett, N., Tapley, A., Andriesen, J. et al. 2022, 'High asymptomatic carriage with the Omicron variant in South Africa', Clinical Infectious Diseases, vol. 75, no. 1, pp. e289-e292, doi : 10.1093/cid/ciac237.en_US
dc.identifier.issn1058-4838 (print)
dc.identifier.issn1537-6591 (online)
dc.identifier.other10.1093/cid/ciac237
dc.identifier.urihttp://hdl.handle.net/2263/90659
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.rights© The Author(s) 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.subjectOmicron varianten_US
dc.subjectAsymptomatic carriageen_US
dc.subjectPWHen_US
dc.subjectSouth Africa (SA)en_US
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_US
dc.subjectHuman immunodeficiency virus (HIV)en_US
dc.subjectPolymerase chain reaction (PCR)en_US
dc.titleHigh asymptomatic carriage with the Omicron variant in South Africaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Garrett_High_2022.pdf
Size:
401.8 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Garrett_HighSuppl_2022.pdf
Size:
293.6 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: